Correlation Between Trevi Therapeutics and Coya Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Trevi Therapeutics and Coya Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Trevi Therapeutics and Coya Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Trevi Therapeutics and Coya Therapeutics, Common, you can compare the effects of market volatilities on Trevi Therapeutics and Coya Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Trevi Therapeutics with a short position of Coya Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Trevi Therapeutics and Coya Therapeutics,.
Diversification Opportunities for Trevi Therapeutics and Coya Therapeutics,
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between Trevi and Coya is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Trevi Therapeutics and Coya Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coya Therapeutics, Common and Trevi Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Trevi Therapeutics are associated (or correlated) with Coya Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coya Therapeutics, Common has no effect on the direction of Trevi Therapeutics i.e., Trevi Therapeutics and Coya Therapeutics, go up and down completely randomly.
Pair Corralation between Trevi Therapeutics and Coya Therapeutics,
Given the investment horizon of 90 days Trevi Therapeutics is expected to generate 1.14 times more return on investment than Coya Therapeutics,. However, Trevi Therapeutics is 1.14 times more volatile than Coya Therapeutics, Common. It trades about 0.06 of its potential returns per unit of risk. Coya Therapeutics, Common is currently generating about 0.03 per unit of risk. If you would invest 185.00 in Trevi Therapeutics on September 14, 2024 and sell it today you would earn a total of 240.50 from holding Trevi Therapeutics or generate 130.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 99.6% |
| Values | Daily Returns |
Trevi Therapeutics vs. Coya Therapeutics, Common
Performance |
| Timeline |
| Trevi Therapeutics |
| Coya Therapeutics, Common |
Trevi Therapeutics and Coya Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Trevi Therapeutics and Coya Therapeutics,
The main advantage of trading using opposite Trevi Therapeutics and Coya Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Trevi Therapeutics position performs unexpectedly, Coya Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coya Therapeutics, will offset losses from the drop in Coya Therapeutics,'s long position.| Trevi Therapeutics vs. Cue Biopharma | Trevi Therapeutics vs. AN2 Therapeutics | Trevi Therapeutics vs. Bioatla | Trevi Therapeutics vs. Spero Therapeutics |
| Coya Therapeutics, vs. Cue Biopharma | Coya Therapeutics, vs. Lantern Pharma | Coya Therapeutics, vs. Fennec Pharmaceuticals | Coya Therapeutics, vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stocks Directory Find actively traded stocks across global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |